Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

MicroSectors FANG and Innovation 3X Leveraged ETNTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

MicroSectors FANG and Innovation 3X Leveraged ETN vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $33.04 (market cap $2.93B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 3.6× MicroSectors FANG and Innovation 3X Leveraged ETN's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while MicroSectors FANG and Innovation 3X Leveraged ETN pays none. Which is the better fit depends on your goals — on Pluang, investors hold MicroSectors FANG and Innovation 3X Leveraged ETN for 20 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

FNGURDY
Market Cap
$2.93B$10.61B
Volume
5,898,6963,738,869
Sector
Leveraged / InverseHealth
52-Week High
$37.20$15.38
52-Week Low
$13.73$11.38
Typical Hold Time
20 Days0 Days
Enterprise Value
—$10.51B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MicroSectors FANG and Innovation 3X Leveraged ETN

FNGU, a 3X leveraged ETN tracking major tech stocks, trades at $36.69 with a slight 0.22% daily gain. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest potential overbought conditions. The ETN provides triple exposure to tech giants like Nvidia and Apple but carries significant volatility risks as highlighted by recent analysis of its 87% decline during previous market downturns.

The outlook remains tied to the performance of underlying tech stocks, offering amplified gains in bullish markets but severe losses during corrections. Key risks include leverage decay, concentration in mega-cap tech, and market volatility. Investors should weigh the potential for high returns against the substantial downside exposure inherent in leveraged products.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FNGU
100% Buy0% Sell
Avg holding period · 20 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About MicroSectors FANG and Innovation 3X Leveraged ETN

FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.

Read more on FNGU →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →